IBDEI29G ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,37971,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,37971,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,37972,0)
 ;;=C79.32^^175^1909^20
 ;;^UTILITY(U,$J,358.3,37972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37972,1,3,0)
 ;;=3^Secondary Malig Neop Cerebral Meninges
 ;;^UTILITY(U,$J,358.3,37972,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,37972,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,37973,0)
 ;;=C79.31^^175^1909^19
 ;;^UTILITY(U,$J,358.3,37973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37973,1,3,0)
 ;;=3^Secondary Malig Neop Brain
 ;;^UTILITY(U,$J,358.3,37973,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,37973,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,37974,0)
 ;;=C7B.03^^175^1909^18
 ;;^UTILITY(U,$J,358.3,37974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37974,1,3,0)
 ;;=3^Secondary Malig Neop Bone
 ;;^UTILITY(U,$J,358.3,37974,1,4,0)
 ;;=4^C7B.03
 ;;^UTILITY(U,$J,358.3,37974,2)
 ;;=^5001384
 ;;^UTILITY(U,$J,358.3,37975,0)
 ;;=C81.90^^175^1909^3
 ;;^UTILITY(U,$J,358.3,37975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37975,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec
 ;;^UTILITY(U,$J,358.3,37975,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,37975,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,37976,0)
 ;;=C81.99^^175^1909^2
 ;;^UTILITY(U,$J,358.3,37976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37976,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal & Solid Organ Sites,Unspec
 ;;^UTILITY(U,$J,358.3,37976,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,37976,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,37977,0)
 ;;=E86.1^^175^1910^13
 ;;^UTILITY(U,$J,358.3,37977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37977,1,3,0)
 ;;=3^Hypovolemia
 ;;^UTILITY(U,$J,358.3,37977,1,4,0)
 ;;=4^E86.1
 ;;^UTILITY(U,$J,358.3,37977,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,37978,0)
 ;;=E85.9^^175^1910^2
 ;;^UTILITY(U,$J,358.3,37978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37978,1,3,0)
 ;;=3^Amyloidosis,Unspec
 ;;^UTILITY(U,$J,358.3,37978,1,4,0)
 ;;=4^E85.9
 ;;^UTILITY(U,$J,358.3,37978,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,37979,0)
 ;;=J34.9^^175^1910^14
 ;;^UTILITY(U,$J,358.3,37979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37979,1,3,0)
 ;;=3^Nose & Nasal Sinuses Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,37979,1,4,0)
 ;;=4^J34.9
 ;;^UTILITY(U,$J,358.3,37979,2)
 ;;=^5008212
 ;;^UTILITY(U,$J,358.3,37980,0)
 ;;=Q21.1^^175^1910^6
 ;;^UTILITY(U,$J,358.3,37980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37980,1,3,0)
 ;;=3^Atrial Septal Defect
 ;;^UTILITY(U,$J,358.3,37980,1,4,0)
 ;;=4^Q21.1
 ;;^UTILITY(U,$J,358.3,37980,2)
 ;;=^186788
 ;;^UTILITY(U,$J,358.3,37981,0)
 ;;=R56.9^^175^1910^8
 ;;^UTILITY(U,$J,358.3,37981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37981,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,37981,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,37981,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,37982,0)
 ;;=R57.0^^175^1910^7
 ;;^UTILITY(U,$J,358.3,37982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37982,1,3,0)
 ;;=3^Cardiogenic Shock
 ;;^UTILITY(U,$J,358.3,37982,1,4,0)
 ;;=4^R57.0
 ;;^UTILITY(U,$J,358.3,37982,2)
 ;;=^5019525
 ;;^UTILITY(U,$J,358.3,37983,0)
 ;;=T79.4XXA^^175^1910^17
 ;;^UTILITY(U,$J,358.3,37983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37983,1,3,0)
 ;;=3^Traumatic Shock,Init Encnt
 ;;^UTILITY(U,$J,358.3,37983,1,4,0)
 ;;=4^T79.4XXA
 ;;^UTILITY(U,$J,358.3,37983,2)
 ;;=^5054305
 ;;^UTILITY(U,$J,358.3,37984,0)
 ;;=T78.2XXA^^175^1910^4
 ;;^UTILITY(U,$J,358.3,37984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,37984,1,3,0)
 ;;=3^Anaphylactic Shock,Unspec,Init Encnt
 ;;^UTILITY(U,$J,358.3,37984,1,4,0)
 ;;=4^T78.2XXA
 ;;^UTILITY(U,$J,358.3,37984,2)
 ;;=^5054278
